Trends in Canadian Cannabis Consumption Over Time: A Two-step Meta-analysis of Canadian Household Survey Data

被引:11
作者
Bahji, Anees [1 ,2 ,3 ,4 ]
Kaur, Sandeep [2 ]
Devoe, Dan [3 ]
Patten, Scott [1 ,2 ,3 ]
机构
[1] Univ Calgary, Dept Psychiat, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada
[2] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[3] Mt Royal Univ, Dept Psychol, Calgary, AB, Canada
[4] British Columbia Ctr Subst Use, Vancouver, BC, Canada
基金
美国国家卫生研究院;
关键词
cannabis; meta-analysis; Canada; prevalence; legalization; HETEROGENEITY; USERS;
D O I
10.1097/CXA.0000000000000154
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims: To estimate temporal trends in cannabis consumption in the Canadian household population using national survey data and map changes in cannabis consumption postlegalization in 2018. Methods: In a 2-step meta-analysis approach, we first analyzed each survey year separately by estimating the weighted past-year prevalence (%) of self-reported cannabis use (including just once) with its 95% confidence intervals (CIs). In the next step, to produce aggregate data for each survey year, we pooled prevalences using the DerSimonian and Laird random-effects (determined a priori) meta-analysis model packages in R to estimate the between-study variance (tau(2)) for the inverse variance method, and the Freeman-Tukey Double arcsine transformation. Results: In total, 29 Statistics Canada survey iterations met eligibility for inclusion in the meta-analysis. Reported pastyear prevalences for cannabis use ranged from 4.2% in 1993 to 27% in 2021. The overall prevalence of past-year cannabis use was 11.4% (95% CI, 9.7%-13.3%; 22 surveys; 53,712/474,888 participants; I-2= 99.8%; tau(2)= 0.0048). There was a significant increase in cannabis past-year prevalence in subgroup meta-analyses (P< 0.0001) comparing postlegalization [2018-2021: 25.0% (95% CI, 23%-27%), I-2= 96%] to prelegalization [1985-2017: 9.9% (95% CI, 9%-11%), I-2= 99%]. There was also a significant time trend, with a steady increase in the reported past-year cannabis prevalence over time from 1985 through 2021. Notably, the most recent national estimate of cannabis prevalence from 2021 was nearly 6 times the first estimate from 1985 (27% vs. 5%). Conclusions: The present study is the first to synthesize Canadian household survey data to estimate the temporal trends in cannabis consumption and is the first meta-analysis examining both the prevalence and changes postlegalization of cannabis use in Canada. The evidence indicates increasing past-year cannabis consumption and time, with a statistically significant increase postlegalization. The public health implications of these changes require further study.
引用
收藏
页码:6 / 13
页数:8
相关论文
共 43 条
[21]   INVERSE OF FREEMAN-TUKEY DOUBLE ARCSINE TRANSFORMATION [J].
MILLER, JJ .
AMERICAN STATISTICIAN, 1978, 32 (04) :138-138
[22]   The association between recreational cannabis legalization, commercialization and cannabis-attributable emergency department visits in Ontario, Canada: an interrupted time-series analysis [J].
Myran, Daniel T. ;
Pugliese, Michael ;
Tanuseputro, Peter ;
Cantor, Nathan ;
Rhodes, Emily ;
Taljaard, Monica .
ADDICTION, 2022, 117 (07) :1952-1960
[23]   Unintentional Pediatric Cannabis Exposures After Legalization of Recreational Cannabis in Canada [J].
Myran, Daniel T. ;
Cantor, Nathan ;
Finkelstein, Yaron ;
Pugliese, Michael ;
Guttmann, Astrid ;
Jesseman, Rebecca ;
Tanuseputro, Peter .
JAMA NETWORK OPEN, 2022, 5 (01)
[24]   How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis [J].
Myran, Daniel T. ;
Staykov, Emiliyan ;
Cantor, Nathan ;
Taljaard, Monica ;
Quach, Bradley I. ;
Hawken, Steven ;
Tanuseputro, Peter .
DRUG AND ALCOHOL REVIEW, 2022, 41 (02) :377-385
[25]  
Myran Daniel T, 2019, CMAJ Open, V7, pE454, DOI 10.9778/cmajo.20190012
[26]  
Natl Acad Sci Engn Med, 2017, HEALTH EFFECTS OF CANNABIS AND CANNABINOIDS: THE CURRENT STATE OF EVIDENCE AND RECOMMENDATIONS FOR RESEARCH, P1, DOI 10.17226/24625
[27]   Undue reliance on I2 in assessing heterogeneity may mislead [J].
Ruecker, Gerta ;
Schwarzer, Guido ;
Carpenter, James R. ;
Schumacher, Martin .
BMC MEDICAL RESEARCH METHODOLOGY, 2008, 8 (1)
[28]  
Single EW, 1995, CAN J PUBLIC HEALTH, V86, P397
[29]   A Single-Question Screening Test for Drug Use in Primary Care [J].
Smith, Peter C. ;
Schmidt, Susan M. ;
Allensworth-Davies, Donald ;
Saitz, Richard .
ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (13) :1155-1160
[30]  
Statistics Canada, 2012, CAN TOB US MON SURV